Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Melanoma 1Lymphoma, Follicular 1Colorectal Neoplasms 1

Interventions

Etanercept 3Methotrexate 2Adalimumab 2secukinumab 1purine 1fumaric acid 1deucravacitinib 1apremilast 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Nivolumab 1Methods 1Mesalamine 1Mercaptopurine 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Folic Acid 1Fish Oils 1Fatty Acids, Omega-3 1Exercise 1Eicosapentaenoic Acid 1Educational Status 1Eating 1Early Intervention, Educational 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Psoriasis × secukinumab × Clear all
NCT04571567 2022-04-11

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Icahn School of Medicine at Mount Sinai

Phase 4 Completed
20 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡